Vice President, Head of Oncology Dsicovery and Early Development @ (January 2016 - August 2018)
Full Professor @ (January 2007 - January 2016)
President and Scientific Director @ (January 2006 - January 2016)
Founder and Scientific Director @ Public Population Project in Genomics (January 2004 - January 2016)
Adjunct Professor, Depts of Medicine and Human Genetics @ (January 2007 - January 2011)
Founder and Director @ Genome Quebec Innovation Center (January 2003 - January 2007)
Associate Professor, Depts of Medicine and Human Genetics @ (January 2002 - January 2007)
Associate Physician, Division of Clinical Immunology @ (January 1999 - January 2006)
Associate Director @ Canadian Genetic Diseases Network (January 2001 - January 2005)
Director @ Montreal Genome Centre (January 1996 - December 2002)
Assistant Professor, Depts of Medicine and Human Genetics @ (January 1996 - January 2002)
Professor and Co-Director @ Inter-University Institute for Population Research (January 1997 - January 2001)
Assistant Director of the Center @ (January 1995 - January 2001)
Visiting Assistant Professor, Department of Biology @ (January 1996 - January 2000)
Assistant Physician, Division of Clinical Immunology @ (January 1996 - January 1999)
Research Scientist @ (January 1993 - January 1995)
Thomas Hudson Education
Massachusetts Institute of Technology
(Genetics, Genomics)
1991-1993
McGill University
(Medicine)
1988-1990
Université de Montréal
(Medicine)
1985-1988
Université de Montréal
Doctor of Medicine (Medicine)
1985
McGill University
(Immunology)
1990
Thomas Hudson Summary
Thomas Hudson, based in United States, is currently a Senior Vice Research and Development and Chief Scientific Officer at Abbvie. Thomas Hudson brings experience from previous roles at Abbvie, University of Toronto and Ontario Institute for Cancer Research. Thomas Hudson holds a 1991 - 1993 Massachusetts Institute of Technology. Thomas Hudson has 1 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Thomas Hudson?
Find contact details for 700 million professionals.